|
RXRB expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64435132177232E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08679999999417E-07 |
| Normal-vs-Stage2 |
2.04940000003706E-06 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.90190000310042E-08 |
| Stage1-vs-Stage2 |
1.216190E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
6.028600E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
2.465800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.66418048417472E-13 |
| Normal-vs-AfricanAmerican |
3.86359999993147E-07 |
| Normal-vs-Asian |
4.83070000001362E-07 |
| Caucasian-vs-AfricanAmerican |
2.683600E-01 |
| Caucasian-vs-Asian |
8.041800E-01 |
| AfricanAmerican-vs-Asian |
7.241500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.87369999807785E-08 |
| Normal-vs-Female |
2.9334001894199E-10 |
| Male-vs-Female |
8.476400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.10330000000036E-05 |
| Normal-vs-Extreme_Weight |
2.22139999950244E-07 |
| Normal-vs-Obese |
2.12229999999591E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
9.113200E-01 |
| Normal_Weight-vs-Obese |
9.453600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.618400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76151999999874E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62244999999395E-05 |
| Normal-vs-Age(61-80Yrs) |
1.20109999723894E-09 |
| Normal-vs-Age(81-100Yrs) |
1.86560000003944E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.744400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.364800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.242200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.969800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.142340E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.807400E-04 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.585000E-01 |
| Normal-vs-Grade 3 |
5.608600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
6.997400E-01 |
| Grade 2-vs-Grade 4 |
4.585000E-01 |
| Grade 3-vs-Grade 4 |
5.608600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33709718244768E-11 |
| Normal-vs-N1 |
2.6429999966382E-08 |
| N0-vs-N1 |
9.832400E-01 |
|
|
